DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
JMT-101
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Unknown
JMT-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAPOSIN C (NON-GLYCOSYLATED)
1
Unknown
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Neoplasms
Unknown
SAPOSIN C (NON-GLYCOSYLATED)
×
Maximum Phase:
1
First Approval:
None
UNII:
2N62LTC861
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEPHEDRONE
1
Small molecule
Investigational
Unknown
Unknown
Amphetamine-Related Disorders
Unknown
MEPHEDRONE
×
Maximum Phase:
1
First Approval:
None
UNII:
8BA8T27317
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO
Molecular Weight:
177.25
AlogP:
1.79
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
3.0
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CHO-H01
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Follicular
Unknown
CHO-H01
×
Maximum Phase:
1
First Approval:
None
UNII:
OJ72N0B4UC
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SALCAPROZATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Unknown
SALCAPROZATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
1YTW0422YU
Molecule Type:
Small molecule
Molecular Formula:
C15H20NNaO4
Molecular Weight:
301.32
AlogP:
2.55
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
9.0
Source:
CEVOSTAMAB
1
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
CEVOSTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RO6958688
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
RO6958688
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MFGR1877S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MFGR1877S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R-1487
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
R-1487
×
Maximum Phase:
1
First Approval:
None
UNII:
IO0DCY55NQ
Molecule Type:
Small molecule
Molecular Formula:
C19H18F2N4O3
Molecular Weight:
388.37
AlogP:
2.99
PSA:
78.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BTA-9881
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Unknown
BTA-9881
×
Maximum Phase:
1
First Approval:
None
UNII:
9VR1J6U4XG
Molecule Type:
Small molecule
Molecular Formula:
C21H15ClN4O2
Molecular Weight:
390.83
AlogP:
2.94
PSA:
66.4
HBD:
0.0
HBA:
#RotB:
2.0
Source:
JNJ-42396302
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-42396302
×
Maximum Phase:
1
First Approval:
None
UNII:
P5M4972608
Molecule Type:
Small molecule
Molecular Formula:
C19H23N5O2
Molecular Weight:
353.43
AlogP:
2.13
PSA:
64.78
HBD:
0.0
HBA:
#RotB:
5.0
Source:
NACUBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Gram-Negative Bacterial Infections; Kidney Diseases; Urinary Tract Infections
Unknown
NACUBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
832O37V7MZ
Molecule Type:
Small molecule
Molecular Formula:
C9H16N4O7S
Molecular Weight:
324.32
AlogP:
-2.0
PSA:
151.5
HBD:
3.0
HBA:
#RotB:
6.0
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
XANTHOHUMOL
1
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
Unknown
XANTHOHUMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
T4467YT1NT
Molecule Type:
Small molecule
Molecular Formula:
C21H22O5
Molecular Weight:
354.4
AlogP:
4.22
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FLANVOTUMAB
1
Antibody
Investigational
Unknown
Unknown
Melanoma
5,6-dihydroxyindole-2-carboxylic acid oxidase other
FLANVOTUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
ZNV4738BS6
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
TAK-580
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TAK-580
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PWT-33579
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase p110-alpha subunit inhibitor
PWT-33579
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALEPLASININ
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Plasminogen activator inhibitor-1 inhibitor
ALEPLASININ
×
Maximum Phase:
1
First Approval:
None
UNII:
LL56J87F3X
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3
Molecular Weight:
425.53
AlogP:
6.23
PSA:
59.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DV-281
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
DV-281
×
Maximum Phase:
1
First Approval:
None
UNII:
4LOR72V17G
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FARALIMOMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Interferon alpha-1/13 binding agent
FARALIMOMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHA-793887
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
PHA-793887
×
Maximum Phase:
1
First Approval:
None
UNII:
MKS45S912B
Molecule Type:
Small molecule
Molecular Formula:
C19H31N5O2
Molecular Weight:
361.49
AlogP:
2.31
PSA:
81.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
INCAGN-02385
1
Unknown
Investigational
Unknown
Unknown
Melanoma
Unknown
INCAGN-02385
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0A08C63DF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIGAPOTIDE TRIFLUTATE
1
Protein
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
TIGAPOTIDE TRIFLUTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
6227JFW01C
Molecule Type:
Protein
Molecular Formula:
C84H120F3N21O36S3
Molecular Weight:
2153.19
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LYMPHOCYTE ACTIVATION GENE 3 PROTEIN
1
Unknown
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Unknown
LYMPHOCYTE ACTIVATION GENE 3 PROTEIN
×
Maximum Phase:
1
First Approval:
None
UNII:
AK0JDV1ZK5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY3185643
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3185643
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
78
79
80
81
82
83
84
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA